These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 10877456)

  • 21. Influenza-induced tachypnea is prevented in immune cotton rats, but cannot be treated with an anti-inflammatory steroid or a neuraminidase inhibitor.
    Eichelberger MC; Prince GA; Ottolini MG
    Virology; 2004 May; 322(2):300-7. PubMed ID: 15110527
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel approach to antiviral therapy for influenza.
    Colman PM
    J Antimicrob Chemother; 1999 Nov; 44 Suppl B():17-22. PubMed ID: 10877458
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of efficacies of RWJ-270201, zanamivir, and oseltamivir against H5N1, H9N2, and other avian influenza viruses.
    Govorkova EA; Leneva IA; Goloubeva OG; Bush K; Webster RG
    Antimicrob Agents Chemother; 2001 Oct; 45(10):2723-32. PubMed ID: 11557461
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuraminidase inhibitors for treatment of influenza A and B infections.
    MMWR Recomm Rep; 1999 Dec; 48(RR-14):1-9. PubMed ID: 10632443
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel means of identifying the neuraminidase type of currently circulating human A(H1) influenza viruses.
    Hurt AC; Barr IG; Komadina N; Hampson AW
    Virus Res; 2004 Jul; 103(1-2):79-83. PubMed ID: 15163493
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oseltamivir resistance in influenza A (H5N1) infection.
    Gupta RK; Nguyen-Van-Tam JS
    N Engl J Med; 2006 Mar; 354(13):1423-4; author reply 1423-4. PubMed ID: 16571890
    [No Abstract]   [Full Text] [Related]  

  • 27. [Critical review of anti-influenza drugs].
    van Loon FP; Voordouw AC; Simonian S; Koopmans PP
    Ned Tijdschr Geneeskd; 2000 Jan; 144(4):165-7. PubMed ID: 10668542
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of influenza with neuraminidase inhibitors: virological implications.
    Roberts NA
    Philos Trans R Soc Lond B Biol Sci; 2001 Dec; 356(1416):1895-7. PubMed ID: 11779389
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phenotypic drug susceptibility assay for influenza virus neuraminidase inhibitors.
    McSharry JJ; McDonough AC; Olson BA; Drusano GL
    Clin Diagn Lab Immunol; 2004 Jan; 11(1):21-8. PubMed ID: 14715540
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuraminidase inhibitors in the management of influenza--experience of an outpatient practice.
    Vogel GE
    Med Microbiol Immunol; 2002 Dec; 191(3-4):161-3. PubMed ID: 12458352
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [symbol: see text] Zanamivir for influenza.
    Drug Ther Bull; 1999 Nov; 37(11):81-4. PubMed ID: 10696691
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The interaction of neuraminidase and hemagglutinin mutations in influenza virus in resistance to 4-guanidino-Neu5Ac2en.
    Blick TJ; Sahasrabudhe A; McDonald M; Owens IJ; Morley PJ; Fenton RJ; McKimm-Breschkin JL
    Virology; 1998 Jun; 246(1):95-103. PubMed ID: 9656997
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Virology. The origin and control of pandemic influenza.
    Laver G; Garman E
    Science; 2001 Sep; 293(5536):1776-7. PubMed ID: 11546857
    [No Abstract]   [Full Text] [Related]  

  • 34. Efficacy and safety of the neuraminidase inhibitor zanamivirin the treatment of influenza A and B virus infections.
    Monto AS; Fleming DM; Henry D; de Groot R; Makela M; Klein T; Elliott M; Keene ON; Man CY
    J Infect Dis; 1999 Aug; 180(2):254-61. PubMed ID: 10395837
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of influenza A/HongKong/156/97 (H5N1) virus in a mouse model and protective effect of zanamivir on H5N1 infection in mice.
    Gubareva LV; McCullers JA; Bethell RC; Webster RG
    J Infect Dis; 1998 Dec; 178(6):1592-6. PubMed ID: 9815209
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Oral neuraminidase inhibitor and an early warning system. New weapons against influenza].
    Lange W; Vogel GE
    MMW Fortschr Med; 2003 Jan; 145(3-4):36-7. PubMed ID: 12619232
    [No Abstract]   [Full Text] [Related]  

  • 37. Evidence for zanamivir resistance in an immunocompromised child infected with influenza B virus.
    Gubareva LV; Matrosovich MN; Brenner MK; Bethell RC; Webster RG
    J Infect Dis; 1998 Nov; 178(5):1257-62. PubMed ID: 9780244
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuraminidase-Inhibiting Antibody Titers Correlate with Protection from Heterologous Influenza Virus Strains of the Same Neuraminidase Subtype.
    Walz L; Kays SK; Zimmer G; von Messling V
    J Virol; 2018 Sep; 92(17):. PubMed ID: 29925654
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influenza A viruses lacking sialidase activity can undergo multiple cycles of replication in cell culture, eggs, or mice.
    Hughes MT; Matrosovich M; Rodgers ME; McGregor M; Kawaoka Y
    J Virol; 2000 Jun; 74(11):5206-12. PubMed ID: 10799596
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Influenza: from vaccine prevention to antiviral therapy].
    Nkoghe D; Scheen AJ
    Rev Med Liege; 2000 Jan; 55(1):19-23. PubMed ID: 10803033
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.